Terminology Service for NFDI4Health
Ofatumumab Regimen
Go to external page
http://purl.obolibrary.org/obo/NCIT_C160096
An immunotherapy regimen consisting of ofatumumab that may be used in the treatment of chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), and Waldenstrom's macroglobulinemia (WM)/lymphoplasmacytic lymphoma (LPL). [ ]
Term info
Label
Ofatumumab Regimen
Synonyms
- Arzerra Regimen
- Ofatumumab Regimen
Subsets
NCIT_C160951, NCIT_C160950
Preferred Name
Ofatumumab Regimen
Semantic Type
Therapeutic or Preventive Procedure
code
C160096